Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 24

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Vitamin D and Cardiovascular Diseases: An Update

Haider, Farrookh, Ghafoor, Hashsaam, Hassan, Omar F, Farooqui, Khalid, Bel Khair, Ali O. Mohamed, Shoaib, Faryal·2023·Cureus
DOI 10.7759/cureus.49734
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7759/cureus.49734

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 188

  1. Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens. 2018, 24:9. 10.1186/s40885-018-0094-4 · DOI
  2. Artaza JN, Contreras S, Garcia LA, et al.. Vitamin D and cardiovascular disease: potential role in health disparities. J Health Care Poor Underserved. 2011, 22:23-38. 10.1353/hpu.2011.0161 · DOI
  3. Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J. 2010, 9:65. 10.1186/1475-2891-9-65 · DOI · Paper page
  4. Demer LL, Hsu JJ, Tintut Y. Steroid hormone vitamin D: implications for cardiovascular disease. Circ Res. 2018, 122:1576-85. 10.1161/CIRCRESAHA.118.311585 · DOI
  5. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004, 80:1689S-96S. 10.1093/ajcn/80.6.1689S · DOI · Paper page
  6. Kessi-Pérez EI, González A, Palacios JL, Martínez C. Yeast as a biological platform for vitamin D production: a promising alternative to help reduce vitamin D deficiency in humans. Yeast. 2022, 39:482-92. 10.1002/yea.3708 · DOI
  7. Guo J, Lovegrove JA, Givens DI. 25(OH)D3-enriched or fortified foods are more efficient at tackling inadequate vitamin D status than vitamin D3. Proc Nutr Soc. 2018, 77:282-91. 10.1017/S0029665117004062 · DOI
  8. Jorge AJL, Cordeiro JR, Rosa MLG, Bianchi DBC. Vitamin D deficiency and cardiovascular diseases. Int J Cardiovasc Sci. 2018, 31:422-32. 10.5935/2359-4802.20180025 · DOI
  9. Zittermann A, Pilz S. Vitamin D and cardiovascular disease: an update. Anticancer Res. 2019, 39:4627-35. 10.21873/anticanres.13643 · DOI
  10. Wang TJ. Vitamin D and cardiovascular disease. Annu Rev Med. 2016, 67:261-72. 10.1146/annurev-med-051214-025146 · DOI
  11. Hagău AC, Pușcaș A, Togănel R, Muntean I. Is hypovitaminosis D a risk factor for heart failure?. Life (Basel). 2023, 13:372. 10.3390/life13020372 · DOI
  12. de la Guía-Galipienso F, Martínez-Ferran M, Vallecillo N, Lavie CJ, Sanchis-Gomar F, Pareja-Galeano H. Vitamin D and cardiovascular health. Clin Nutr. 2021, 40:2946-57. 10.1016/j.clnu.2020.12.025 · DOI · Paper page
  13. Charoenngam N, Shirvani A, Holick MF. Vitamin D for skeletal and non-skeletal health: what we should know. J Clin Orthop Trauma. 2019, 10:1082-93. 10.1016/j.jcot.2019.07.004 · DOI · Paper page
  14. Pludowski P, Holick MF, Grant WB, et al.. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018, 175:125-35. 10.1016/j.jsbmb.2017.01.021 · DOI · Paper page
  15. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006, 116:2062-72. 10.1172/JCI29449 · DOI · Paper page
  16. Cooke NE, Haddad JG. Vitamin D binding protein (Gc-globulin). Endocr Rev. 1989, 10:294-307. 10.1210/edrv-10-3-294 · DOI · Paper page
  17. Valero Zanuy MÁ, Hawkins Carranza F. Metabolism, endogenous and exogenous sources of vitamin D. Rev Esp Enfermedades Metab Oseas. 2007, 16:63-70. 10.1016/S1132-8460(07)73506-7 · DOI
  18. Lehmann B, Tiebel O, Meurer M. Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents: a preliminary study. Arch Dermatol Res. 1999, 291:507-10. 10.1007/s004030050445 · DOI
  19. Bikle DD, Nemanic MK, Whitney JO, Elias PW. Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. Biochemistry. 1986, 25:1545-8. 10.1021/bi00355a013 · DOI
  20. Vantieghem K, Kissmeyer AM, De Haes P, Bouillon R, Segaert S. UVB-induced production of 1,25-dihydroxyvitamin D3 and vitamin D activity in human keratinocytes pretreated with a sterol delta7-reductase inhibitor. J Cell Biochem. 2006, 98:81-92. 10.1002/jcb.20756 · DOI
  21. Segaert S, Simonart T. The epidermal vitamin D system and innate immunity: some more light shed on this unique photoendocrine system?. Dermatology. 2008, 217:7-11. 10.1159/000118506 · DOI
  22. Bikle DD. Vitamin D regulated keratinocyte differentiation. J Cell Biochem. 2004, 92:436-44. 10.1002/jcb.20095 · DOI
  23. Chowdhury R, Kunutsor S, Vitezova A, et al.. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014, 348:g1903. 10.1136/bmj.g1903 · DOI · Paper page
  24. Bikle D, Christakos S. New aspects of vitamin D metabolism and action - addressing the skin as source and target. Nat Rev Endocrinol. 2020, 16:234-52. 10.1038/s41574-019-0312-5 · DOI · Paper page
  25. Maretzke F, Bechthold A, Egert S, et al.. Role of vitamin D in preventing and treating selected extraskeletal diseases—an umbrella review. Nutrients. 2020, 12:1-36. 10.3390/nu12040969 · DOI
  26. Siotto M, Santoro M, Aprile I. Vitamin D and rehabilitation after stroke: status of art. Appl Sci. 2020, 10:1973. 10.3390/app10061973 · DOI
  27. Ross CA, Taylor CL, Yaktime AL, et al.. Dietary Reference Intakes for Calcium and Vitamin; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. National Academies Press, Washington, DC; 2011. 10.17226/13050 · DOI · Paper page
  28. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011, 96:1911-30. 10.1210/jc.2011-0385 · DOI · Paper page
  29. Romagnoli E, Carnevale V, Biondi P, Minisola S. Vitamin D supplementation: when and how?. J Endocrinol Invest. 2014, 37:603-7. 10.1007/s40618-014-0071-z · DOI
  30. Zittermann A, Trummer C, Theiler-Schwetz V, Lerchbaum E, März W, Pilz S. Vitamin D and cardiovascular disease: an updated narrative review. Int J Mol Sci. 2021, 22:2896. 10.3390/ijms22062896 · DOI
  31. Cosentino N, Campodonico J, Milazzo V, De Metrio M, Brambilla M, Camera M, Marenzi G. Vitamin D and cardiovascular disease: current evidence and future perspectives. Nutrients. 2021, 13:3603. 10.3390/nu13103603 · DOI
  32. Khammissa RA, Fourie J, Motswaledi MH, Ballyram R, Lemmer J, Feller L. The biological activities of vitamin D and its receptor in relation to calcium and bone homeostasis, cancer, immune and cardiovascular systems, skin biology, and oral health. Biomed Res Int. 2018, 2018:9276380. 10.1155/2018/9276380 · DOI · Paper page
  33. Hiemstra TF, Lim K, Thadhani R, Manson JE. Vitamin D and atherosclerotic cardiovascular disease. J Clin Endocrinol Metab. 2019, 104:4033-50. 10.1210/jc.2019-00194 · DOI
  34. Freundlich M, Li YC, Quiroz Y, et al.. Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats. Am J Hypertens. 2013, 27:720-6. 10.1093/ajh/hpt177 · DOI
  35. Cui C, Xu P, Li G, et al.. Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system. Redox Biol. 2019, 26:101295. 10.1016/j.redox.2019.101295 · DOI
  36. Oh J, Matkovich SJ, Riek AE, et al.. Macrophage secretion of miR-106b-5p causes renin-dependent hypertension. Nat Commun. 2020, 11:4798. 10.1038/s41467-020-18538-x · DOI
  37. Polly P, Tan TC. The role of vitamin D in skeletal and cardiac muscle function. Front Physiol. 2014, 5:145. 10.3389/fphys.2014.00145 · DOI
  38. Zittermann A. Vitamin D status, supplementation and cardiovascular disease. Anticancer Res. 2018, 38:1179-86. 10.21873/anticanres.12338 · DOI
  39. Nakashima A, Yokoyama K, Yokoo T, Urashima M. Role of vitamin D in diabetes mellitus and chronic kidney disease. World J Diabetes. 2016, 7:89-100. 10.4239/wjd.v7.i5.89 · DOI
  40. Roffe-Vazquez DN, Huerta-Delgado AS, Castillo EC, et al.. Correlation of Vitamin D with inflammatory cytokines, atherosclerotic parameters, and lifestyle factors in the setting of heart failure: a 12-month follow-up study. Int J Mol Sci. 2019, 20:5811. 10.3390/ijms20225811 · DOI
  41. Latic N, Erben RG. Vitamin D and cardiovascular disease, with emphasis on hypertension, atherosclerosis, and heart failure. Int J Mol Sci. 2020, 21:6483. 10.3390/ijms21186483 · DOI · Paper page
  42. Condoleo V, Pelaia C, Armentaro G, et al.. Role of vitamin D in cardiovascular diseases. Endocrines. 2021, 2:417-26. 10.3390/endocrines2040037 · DOI
  43. Adams JS, Ren S, Liu PT, et al.. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol. 2009, 182:4289-95. 10.4049/jimmunol.0803736 · DOI · Paper page
  44. Dickie LJ, Church LD, Coulthard LR, et al.. Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes. Rheumatology. 2010, 49:1466-71. 10.1093/rheumatology/keq124 · DOI
  45. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007, 179:1634-47. 10.4049/jimmunol.179.3.1634 · DOI · Paper page
  46. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001, 167:4974-80. 10.4049/jimmunol.167.9.4974 · DOI · Paper page
  47. Oh J, Weng S, Felton SK, et al.. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 2009, 120:687-98. 10.1161/CIRCULATIONAHA.109.856070 · DOI · Paper page
  48. Yin K, You Y, Swier V, Tang L, Radwan MM, Pandya AN, Agrawal DK. Vitamin D protects against atherosclerosis via regulation of cholesterol efflux and macrophage polarization in hypercholesterolemic swine. Arterioscler Thromb Vasc Biol. 2015, 35:2432-42. 10.1161/ATVBAHA.115.306132 · DOI
  49. Chen S, Swier VJ, Boosani CS, Radwan MM, Agrawal DK. Vitamin D deficiency accelerates coronary artery disease progression in swine. Arterioscler Thromb Vasc Biol. 2016, 36:1651-9. 10.1161/ATVBAHA.116.307586 · DOI
  50. Kasuga H, Hosogane N, Matsuoka K, Mori I, Sakura Y, Shimakawa . Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochem Biophys Res Commun. 2002, 297:1332-8. 10.1016/s0006-291x(02)02254-4 · DOI
  51. Carbone F, Satta N, Burger F, et al.. Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages. Vascul Pharmacol. 2016, 85:57-65. 10.1016/j.vph.2016.08.004 · DOI
  52. Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J, Warburton EA. Reduced vitamin D in acute stroke. Stroke. 2006, 37:243-5. 10.1161/01.STR.0000195184.24297.c1 · DOI · Paper page
  53. Liu AJ, Guo JM, Xia W, Su DF. New strategies for the prevention of stroke. Clin Exp Pharmacol Physiol. 2010, 37:265-71. 10.1111/j.1440-1681.2009.05230.x · DOI
  54. Pilz S, Tomaschitz A, Drechsler C, Zittermann A, Dekker JM, März W. Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets. 2011, 12:88-96. 10.2174/138945011793591563 · DOI
  55. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007, 92:2017-29. 10.1210/jc.2007-0298 · DOI · Paper page
  56. Muscogiuri G, Annweiler C, Duval G, et al.. Vitamin D and cardiovascular disease: from atherosclerosis to myocardial infarction and stroke. Int J Cardiol. 2017, 230:577-84. 10.1016/j.ijcard.2016.12.053 · DOI
  57. Brøndum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M. 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol. 2013, 73:38-47. 10.1002/ana.23738 · DOI
  58. Zhou R, Wang M, Huang H, Li W, Hu Y, Wu T. Lower vitamin D status is associated with an increased risk of ischemic stroke: a systematic review and meta-analysis. Nutrients. 2018, 10:277. 10.3390/nu10030277 · DOI
  59. Judd SE, Morgan CJ, Panwar B, et al.. Vitamin D deficiency and incident stroke risk in community-living black and white adults. Int J Stroke. 2016, 11:93-102. 10.1177/1747493015607515 · DOI
  60. Pilz S, Dobnig H, Fischer JE, et al.. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke. 2008, 39:2611-3. 10.1161/STROKEAHA.107.513655 · DOI · Paper page
  61. Makariou SE, Michel P, Tzoufi MS, Challa A, Milionis HJ. Vitamin D and stroke: promise for prevention and better outcome. Curr Vasc Pharmacol. 2014, 12:117-24. 10.2174/15701611113119990119 · DOI
  62. Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019, 380:33-44. 10.1007/s11606-020-05648-x · DOI
  63. Pittas AG, Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol. 2010, 121:425-9. 10.1016/j.jsbmb.2010.03.042 · DOI
  64. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child. 2008, 93:512-7. 10.1136/adc.2007.128579 · DOI · Paper page
  65. Tenconi MT, Devoti G, Comelli M, Pinon M, Capocchiano A, Calcaterra V, Pretti G. Major childhood infectious diseases and other determinants associated with type 1 diabetes: a case-control study. Acta Diabetol. 2007, 44:14-9. 10.1007/s00592-007-0235-9 · DOI
  66. Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, Jacques PF. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009, 139:329-34. 10.3945/jn.108.093831 · DOI · Paper page
  67. Ock SY, Ha KH, Kim BK, et al.. Serum 25-hydroxy vitamin D concentration is independently inversely associated with insulin resistance in the healthy, non-obese Korean population. Diabetes Metab J. 2016, 40:367-75. 10.4093/dmj.2016.40.5.367 · DOI
  68. Nardin M, Verdoia M, Schaffer A, Barbieri L, Marino P, De Luca G. Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography. Atherosclerosis. 2016, 250:114-21. 10.1016/j.atherosclerosis.2016.05.019 · DOI
  69. Schafer AL, Napoli N, Lui L, Schwartz AV, Black DM. Serum 25-hydroxyvitamin D concentration does not independently predict incident diabetes in older women. Diabet Med. 2014, 31:564-9. 10.1111/dme.12368 · DOI
  70. Rai V, Agrawal DK. Role of vitamin D in cardiovascular diseases. Endocrinol Metab Clin North Am. 2017, 46:1039-59. 10.1016/j.ecl.2017.07.009 · DOI
  71. Chen S, Sun Y, Agrawal DK. Vitamin D deficiency and essential hypertension. J Am Soc Hypertens. 2015, 9:885-901. 10.1016/j.jash.2015.08.009 · DOI
  72. Yilmaz S, Sen F, Ozeke O, Temizhan A, Topaloglu S, Aras D, Aydogdu S. The relationship between vitamin D levels and nondipper hypertension. Blood Press Monit. 2015, 20:330-4. 10.1097/MBP.0000000000000146 · DOI
  73. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004, 89-90:387-92. 10.1016/j.jsbmb.2004.03.004 · DOI · Paper page
  74. Zagami RM, Di Pino A, Urbano F, Piro S, Purrello F, Rabuazzo AM. Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c. Atherosclerosis. 2015, 243:395-401. 10.1016/j.atherosclerosis.2015.09.038 · DOI
  75. Kang JY, Kim MK, Jung S, Shin J, Choi BY. The cross-sectional relationships of dietary and serum vitamin D with cardiometabolic risk factors: Metabolic components, subclinical atherosclerosis, and arterial stiffness. Nutrition. 2016, 32:1048-56.e1. 10.1016/j.nut.2016.02.019 · DOI
  76. Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of vitamin D in atherosclerosis. Circulation. 2013, 128:2517-31. 10.1161/CIRCULATIONAHA.113.002654 · DOI · Paper page
  77. Holick MF. Vitamin D deficiency. N Engl J Med. 2007, 357:266-81. 10.1056/NEJMra070553 · DOI · Paper page
  78. Oruc CU, Akpinar YE, Amikishiyev S, Uzum AK, Salmaslioglu A, Gurdol F, Omer B. Hypovitaminosis D is associated with endothelial dysfunction in patients with metabolic syndrome. Curr Vasc Pharmacol. 2017, 15:152-7. 10.2174/1570161114666161003093443 · DOI
  79. Ni W, Watts SW, Ng M, Chen S, Glenn DJ, Gardner DG. Elimination of vitamin D receptor in vascular endothelial cells alters vascular function. Hypertension. 2014, 64:1290-8. 10.1161/HYPERTENSIONAHA.114.03971 · DOI
  80. Sarhan N, Essam Abou Warda A, Alsahali S, Alanazi AS. Dietary reference intakes for calcium and vitamin; committee to review Dietary Reference Intakes for vitamin D and calcium. Pharmaceuticals (Basel). 2023, 16:262. 10.3390/ph16020262 · DOI
  81. De Metrio M, Milazzo V, Rubino M, et al.. Vitamin D plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes: a prospective study. Medicine (Baltimore). 2015, 94:e857. 10.1097/MD.0000000000000857 · DOI
  82. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008, 168:1174-80. 10.1001/archinte.168.11.1174 · DOI · Paper page
  83. Lee JH, Gadi R, Spertus JA, Tang F, O'Keefe JH. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol. 2011, 107:1636-8. 10.1016/j.amjcard.2011.01.048 · DOI
  84. Correia LC, Sodré F, Garcia G, et al.. Relation of severe deficiency of vitamin D to cardiovascular mortality during acute coronary syndromes. Am J Cardiol. 2013, 111:324-7. 10.1016/j.amjcard.2012.10.006 · DOI
  85. Bahrami LS, Ranjbar G, Norouzy A, Arabi SM. Vitamin D supplementation effects on the clinical outcomes of patients with coronary artery disease: a systematic review and meta-analysis. Sci Rep. 2020, 10:12923. 10.1038/s41598-020-69762-w · DOI
  86. LeBoff MS, Murata EM, Cook NR, et al.. Vitamin D and omega-3 trial (VITAL): effects of vitamin D supplements on risk of falls in the US population. J Clin Endocrinol Metab. 2020, 105:2929-38. 10.1210/clinem/dgaa311 · DOI
  87. Lund B, Badskjaer J, Lund B, Soerensen OH. Vitamin D and ischaemic heart disease. Horm Metab Res. 1978, 10:553-6. 10.1055/s-0028-1093390 · DOI
  88. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol. 1990, 19:559-63. 10.1093/ije/19.3.559 · DOI · Paper page
  89. Wang TJ, Pencina MJ, Booth SL, et al.. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008, 117:503-11. 10.1161/CIRCULATIONAHA.107.706127 · DOI · Paper page
  90. Wang L, Song Y, Manson JE, et al.. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012, 5:819-29. 10.1161/CIRCOUTCOMES.112.967604 · DOI · Paper page
  91. Ng LL, Sandhu JK, Squire IB, Davies JE, Jones DJ. Vitamin D and prognosis in acute myocardial infarction. Int J Cardiol. 2013, 168:2341-6. 10.1016/j.ijcard.2013.01.030 · DOI
  92. Aleksova A, Belfiore R, Carriere C, Kassem S, La Carrubba S, Barbati G, Sinagra G. Vitamin D deficiency in patients with acute myocardial infarction: an Italian single-center study. Int J Vitam Nutr Res. 2015, 85:23-30. 10.1024/0300-9831/a000220 · DOI
  93. Khalili H, Talasaz AH, Salarifar M. Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol. 2012, 101:321-7. 10.1007/s00392-011-0394-0 · DOI
  94. De Metrio M, Milazzo V, Marenzi G. Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol. 2012, 101:771-2. 10.1007/s00392-012-0457-x · DOI
  95. Pilz S, März W, Wellnitz B, et al.. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008, 93:3927-35. 10.1210/jc.2008-0784 · DOI · Paper page
  96. Perron RM, Lee P. Efficacy of high-dose vitamin D supplementation in the critically ill patients. Inflamm Allergy Drug Targets. 2013, 12:273-81. 10.2174/18715281113129990047 · DOI
  97. Moromizato T, Litonjua AA, Braun AB, Gibbons FK, Giovannucci E, Christopher KB. Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill. Crit Care Med. 2014, 42:97-107. 10.1097/CCM.0b013e31829eb7af · DOI
  98. Meems LM, Brouwers FP, Joosten MM, et al.. Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort study. ESC Heart Fail. 2016, 3:189-97. 10.1002/ehf2.12089 · DOI
  99. Bae S, Singh SS, Yu H, Lee JY, Cho BR, Kang PM. Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction. J Appl Physiol (1985). 2013, 114:979-87. 10.1152/japplphysiol.01506.2012 · DOI
  100. Gullestad L, Ueland T, Vinge LE, Finsen A, Yndestad A, Aukrust P. Inflammatory cytokines in heart failure: mediators and markers. Cardiology. 2012, 122:23-35. 10.1159/000338166 · DOI · Paper page
  101. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006, 83:754-9. 10.1093/ajcn/83.4.754 · DOI · Paper page
  102. Seki K, Sanada S, Kudinova AY, Steinhauser ML, Handa V, Gannon J, Lee RT. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ Heart Fail. 2009, 2:684-91. 10.1161/CIRCHEARTFAILURE.109.873240 · DOI · Paper page
  103. Yao HC, Li XY, Han QF, et al.. Elevated serum soluble ST2 levels may predict the fatal outcomes in patients with chronic heart failure. Int J Cardiol. 2015, 186:303-4. 10.1016/j.ijcard.2015.03.269 · DOI
  104. Schierbeck LL, Jensen TS, Bang U, Jensen G, Kober L, Jensen JE. Parathyroid hormone and vitamin D--markers for cardiovascular and all-cause mortality in heart failure. Eur J Heart Fail. 2011, 13:626-32. 10.1093/eurjhf/hfr016 · DOI
  105. Pfeffer PE, Chen YH, Woszczek G, et al.. Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33. J Allergy Clin Immunol. 2015, 135:824-7.e3. 10.1016/j.jaci.2014.09.044 · DOI
  106. Gruson D, Ferracin B, Ahn SA, Rousseau MF. Soluble ST2, the vitamin D/PTH axis and the heart: new interactions in the air?. Int J Cardiol. 2016, 212:292-4. 10.1016/j.ijcard.2016.03.063 · DOI
  107. Masson S, Barlera S, Colotta F, et al.. A low plasma 1,25(OH)(2) vitamin D/PTH (1-84) ratio predicts worsening of renal function in patients with chronic heart failure. Int J Cardiol. 2016, 224:220-5. 10.1016/j.ijcard.2016.09.014 · DOI
  108. Jiang WL, Gu HB, Zhang YF, Xia QQ, Qi J, Chen JC. Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol. 2016, 39:56-61. 10.1002/clc.22473 · DOI
  109. Robbins J, Petrone AB, Gaziano JM, Djoussé L. Dietary vitamin D and risk of heart failure in the Physicians' Health Study. Clin Nutr. 2016, 35:650-3. 10.1016/j.clnu.2015.04.011 · DOI
  110. Abu El Maaty MA, Hassanein SI, Gad MZ. Genetic variation in vitamin D receptor gene (Fok1:rs2228570) is associated with risk of coronary artery disease. Biomarkers. 2016, 21:68-72. 10.3109/1354750X.2015.1118535 · DOI
  111. Donneyong MM, Hornung CA, Taylor KC, et al.. Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women's health initiative. Circ Heart Fail. 2015, 8:49-56. 10.1161/CIRCHEARTFAILURE.114.001738 · DOI
  112. Schroten NF, Ruifrok WP, Kleijn L, et al.. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 2013, 166:357-64.e2. 10.1016/j.ahj.2013.05.009 · DOI
  113. Nolte K, Herrmann-Lingen C, Platschek L, et al.. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction. ESC Heart Fail. 2019, 6:262-70. 10.1002/ehf2.12413 · DOI
  114. Ozdemir B. Association between left ventricle ejection fraction and vitamin D levels in congestive heart failure; a cross sectional study. J Pharm Care. 2020, 8:50-2. 10.18502/jpc.v8i2.3827 · DOI
  115. Pandit A, Mookadam F, Boddu S, et al.. Vitamin D levels and left ventricular diastolic function. Open Heart. 2014, 1:e000011. 10.1136/openhrt-2013-000011 · DOI
  116. Liu L, Chen M, Hankins SR, et al.. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. Am J Cardiol. 2012, 110:834-9. 10.1016/j.amjcard.2012.05.013 · DOI
  117. Fan Y, Yang Z, Wang L, et al.. Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms. Front Pharmacol. 2023, 14:1154167. 10.3389/fphar.2023.1154167 · DOI
  118. Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci. 2009, 338:40-4. 10.1097/MAJ.0b013e3181aaee91 · DOI · Paper page
  119. Boxer RS, Kenny AM, Schmotzer BJ, Vest M, Fiutem JJ, Piña IL. A randomized controlled trial of high dose vitamin D3 in patients with heart failure. JACC Heart Fail. 2013, 1:84-90. 10.1016/j.jchf.2012.11.003 · DOI
  120. Dalbeni A, Scaturro G, Degan M, Minuz P, Delva P. Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial. Nutr Metab Cardiovasc Dis. 2014, 24:861-8. 10.1016/j.numecd.2014.02.015 · DOI
  121. Morillo CA, Banerjee A, Perel P, Wood D, Jouven X. Atrial fibrillation: the current epidemic. J Geriatr Cardiol. 2017, 14:195-203. 10.11909/j.issn.1671-5411.2017.03.011 · DOI · Paper page
  122. Freedman B, Hindricks G, Banerjee A, et al.. World heart federation roadmap on atrial fibrillation—a 2020 update. Glob Heart. 2020, 2021:41. 10.5334/gh.1023 · DOI
  123. Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015, 12:230-43. 10.1038/nrcardio.2015.2 · DOI · Paper page
  124. Galea R, Cardillo MT, Caroli A, Marini MG, Sonnino C, Narducci ML, Biasucci LM. Inflammation and C-reactive protein in atrial fibrillation: cause or effect?. Tex Heart Inst J. 2014, 41:461-8. 10.14503/THIJ-13-3466 · DOI
  125. Patel D, Druck A, Hoppensteadt D, Bansal V, Brailovsky Y, Syed M, Fareed J. Relationship Between 25-Hydroxyvitamin D, Renin, and Collagen Remodeling Biomarkers in Atrial Fibrillation. Clin Appl Thromb Hemost. 2020, 26:1076029619899702. 10.1177/1076029619899702 · DOI
  126. Zhang Z, Yang Y, Ng CY, Wang D, Wang J, Li G, Liu T. Meta-analysis of vitamin D deficiency and risk of atrial fibrillation. Clin Cardiol. 2016, 39:537-43. 10.1002/clc.22563 · DOI · Paper page
  127. Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circ Res. 2014, 114:379-93. 10.1161/CIRCRESAHA.113.301241 · DOI · Paper page
  128. Demir M, Uyan U, Melek M. The effects of vitamin D deficiency on atrial fibrillation. Clin Appl Thromb Hemost. 2014, 20:98-103. 10.1177/1076029612453762 · DOI
  129. Chen WR, Liu ZY, Shi Y, Yin DW, Wang H, Sha Y, Chen YD. Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients. Ann Noninvasive Electrocardiol. 2014, 19:166-73. 10.1111/anec.12105 · DOI
  130. Rienstra M, Cheng S, Larson MG, et al.. Vitamin D status is not related to development of atrial fibrillation in the community. Am Heart J. 2011, 162:538-41. 10.1016/j.ahj.2011.06.013 · DOI
  131. Alonso A, Misialek JR, Michos ED, et al.. Serum 25-hydroxyvitamin D and the incidence of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study. Europace. 2016, 18:1143-9. 10.1093/europace/euv395 · DOI
  132. Özsin KK, Sanrı US, Toktaş F, Kahraman N, Yavuz Ş. Effect of plasma level of vitamin D on postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting. Braz J Cardiovasc Surg. 2018, 33:217-23. 10.21470/1678-9741-2017-0214 · DOI
  133. Gode S, Aksu T, Demirel A, Sunbul M, Gul M, Bakır I, Yeniterzi M. Effect of vitamin D deficiency on the development of postoperative atrial fibrillation in coronary artery bypass patients. J Cardiovasc Thorac Res. 2016, 8:140-6. 10.15171/jcvtr.2016.29 · DOI
  134. Liu X, Wang W, Tan Z, Zhu X, Liu M, Wan R, Hong K. The relationship between vitamin D and risk of atrial fibrillation: a dose-response analysis of observational studies. Nutr J. 2019, 18:73. 10.1186/s12937-019-0485-8 · DOI
  135. Cerit L, Özcem B, Cerit Z, Duygu H. Preventive effect of preoperative vitamin D supplementation on postoperative atrial fibrillation. Braz J Cardiovasc Surg. 2018, 33:347-52. 10.21470/1678-9741-2018-0014 · DOI
  136. Belen E, Aykan AC, Kalaycioglu E, Sungur MA, Sungur A, Cetin M. Low-level vitamin D is associated with atrial fibrillation in patients with chronic heart failure. Adv Clin Exp Med. 2016, 25:51-7. 10.17219/acem/34690 · DOI
  137. Surdu AM, Pînzariu O, Ciobanu DM, et al.. Vitamin D and its role in the lipid metabolism and the development of atherosclerosis. Biomedicines. 2021, 9:172. 10.3390/biomedicines9020172 · DOI
  138. Dziedzic EA, Przychodzeń S, Dąbrowski M. The effects of vitamin D on severity of coronary artery atherosclerosis and lipid profile of cardiac patients. Arch Med Sci. 2016, 12:1199-206. 10.5114/aoms.2016.60640 · DOI
  139. Lupton JR, Faridi KF, Martin SS, Sharma S, Kulkarni K, Jones SR, Michos ED. Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: the very large database of lipids (VLDL-3) study. J Clin Lipidol. 2016, 10:72-81.e1. 10.1016/j.jacl.2015.09.006 · DOI
  140. Manousopoulou A, Al-Daghri NM, Garbis SD, Chrousos GP. Vitamin D and cardiovascular risk among adults with obesity: a systematic review and meta-analysis. Eur J Clin Invest. 2015, 45:1113-26. 10.1111/eci.12510 · DOI
  141. Mirhosseini N, Rainsbury J, Kimball SM. Vitamin D supplementation, serum 25(OH)D concentrations and cardiovascular disease risk factors: a systematic review and meta-analysis. Front Cardiovasc Med. 2018, 5:87. 10.3389/fcvm.2018.00087 · DOI
  142. Asbaghi O, Kashkooli S, Choghakhori R, Hasanvand A, Abbasnezhad A. Effect of calcium and vitamin D co-supplementation on lipid profile of overweight/obese subjects: a systematic review and meta-analysis of the randomized clinical trials. Obes Med. 2019, 15:100124. 10.1016/j.obmed.2019.100124 · DOI
  143. Sidabutar E, Halim B, Siregar MFG, Lutan D, Adenin I, Kaban Y, idabutar E. Vitamin D levels in women with polycystic ovary syndrome. KnE Med. 2016, 1:2831. 10.18502/kme.v1i1.547 · DOI
  144. Gokosmanoglu F, Onmez A, Ergenç H. The relationship between Vitamin D deficiency and polycystic ovary syndrome. Afr Health Sci. 2020, 20:1880-6. 10.4314/ahs.v20i4.45 · DOI
  145. Miao CY, Fang XJ, Chen Y, Zhang Q. Effect of vitamin D supplementation on polycystic ovary syndrome: a meta-analysis. Exp Ther Med. 2020, 19:2641-9. 10.3892/etm.2020.8525 · DOI
  146. Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. Nutrients. 2020, 12:2097. 10.3390/nu12072097 · DOI · Paper page
  147. Manson JE, Cook NR, Lee IM, et al.. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019, 380:33-44. 10.1056/NEJMoa1809944 · DOI · Paper page
  148. Hsia J, Heiss G, Ren H, et al.. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007, 115:846-54. 10.1161/CIRCULATIONAHA.106.673491 · DOI · Paper page
  149. Dalan R, Liew H, Assam PN, et al.. A randomised controlled trial evaluating the impact of targeted vitamin D supplementation on endothelial function in type 2 diabetes mellitus: the DIMENSION trial. Diab Vasc Dis Res. 2016, 13:192-200. 10.1177/1479164115621667 · DOI
  150. Aslanabadi N, Jafaripor I, Sadeghi S, et al.. Effect of vitamin D in the prevention of myocardial injury following elective percutaneous coronary intervention: a pilot randomized clinical trial. J Clin Pharmacol. 2018, 58:144-51. 10.1002/jcph.989 · DOI
  151. Hin H, Tomson J, Newman C, et al.. Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care. Osteoporos Int. 2017, 28:841-51. 10.1007/s00198-016-3833-y · DOI
  152. Neale RE, Armstrong BK, Baxter C, et al.. The D-Health trial: a randomized trial of vitamin D for prevention of mortality and cancer. Contemp Clin Trials. 2016, 48:83-90. 10.1016/j.cct.2016.04.005 · DOI
  153. Legarth C, Grimm D, Krüger M, Infanger M, Wehland M. Potential beneficial effects of vitamin D in coronary artery disease. Nutrients. 2019, 12:99. 10.3390/nu12010099 · DOI
  154. Seibert E, Lehmann U, Riedel A, et al.. Vitamin D(3) supplementation does not modify cardiovascular risk profile of adults with inadequate vitamin D status. Eur J Nutr. 2017, 56:621-34. 10.1007/s00394-015-1106-8 · DOI
  155. Gholami F, Moradi G, Zareei B, Rasouli MA, Nikkhoo B, Roshani D, Ghaderi E. The association between circulating 25-hydroxyvitamin D and cardiovascular diseases: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disord. 2019, 19:248. 10.1186/s12872-019-1236-7 · DOI
  156. Barbarawi M, Kheiri B, Zayed Y, et al.. Vitamin D supplementation and cardiovascular disease risks in more than 83,000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiol. 2019, 4:765-76. 10.1001/jamacardio.2019.1870 · DOI · Paper page
  157. McNally JD, Menon K. Vitamin D deficiency in surgical congenital heart disease: prevalence and relevance. Transl Pediatr. 2013, 2:99-111. 10.3978/j.issn.2224-4336.2013.07.03 · DOI
  158. Gallo S, Comeau K, Vanstone C, et al.. Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy, breastfed infants: a randomized trial. JAMA. 2013, 309:1785-92. 10.1001/jama.2013.3404 · DOI
  159. Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating vitamin D3 and 25-hydroxyvitamin D in humans: an important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol. 2007, 103:631-4. 10.1016/j.jsbmb.2006.12.066 · DOI
  160. Schlingmann KP, Kaufmann M, Weber S, et al.. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011, 365:410-21. 10.1056/NEJMoa1103864 · DOI · Paper page
  161. Morris CA, Braddock SR. Health care supervision for children with Williams syndrome. Pediatrics. 2020, 145:1192-204. 10.1542/peds.2019-3761 · DOI
  162. Ammenti A, Pelizzoni A, Cecconi M, Molinari PP, Montini G. Nephrocalcinosis in children: a retrospective multi-centre study. Acta Paediatr. 2009, 98:1628-31. 10.1111/j.1651-2227.2009.01401.x · DOI
  163. Mantan M, Bagga A, Virdi VS, Menon S, Hari P. Etiology of nephrocalcinosis in northern Indian children. Pediatr Nephrol. 2007, 22:829-33. 10.1007/s00467-006-0425-7 · DOI
  164. Atabek ME, Pirgon O, Sert A. Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis. J Pediatr Endocrinol Metab. 2006, 19:169-72. 10.1515/jpem.2006.19.2.169 · DOI
  165. Chambellan-Tison C, Horen B, Plat-Wilson G. Severe hypercalcemia due to vitamin D intoxication. Arch Pediatr. 2007, 14:1328-32. 10.1016/j.arcped.2007.08.005 · DOI
  166. Mallet E, Philippe F, Castanet M, Basuyau JP. Administration of a single Winter oral dose of 200,000 IU of vitamin D3 in adolescents in Normandy: evaluation of the safety and vitamin D status obtained (Article in French). Arch Pediatr. 2010, 17:1042-6. 10.1016/j.arcped.2010.04.013 · DOI
  167. Emel T, Doğan DA, Erdem G, Faruk O. Therapy strategies in vitamin D deficiency with or without rickets: efficiency of low-dose stoss therapy. J Pediatr Endocrinol Metab. 2012, 25:107-10. 10.1515/jpem-2011-0368 · DOI
  168. Aggarwal G, Cheruiyot I, Aggarwal S, et al.. Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: a meta-analysis. Curr Probl Cardiol. 2020, 45:100617. 10.1016/j.cpcardiol.2020.100617 · DOI
  169. Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016/S0140-6736(20)30566-3 · DOI · Paper page
  170. Driggin E, Madhavan MV, Bikdeli B, et al.. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020, 75:2352-71. 10.1016/j.jacc.2020.03.031 · DOI · Paper page
  171. Beltrán-García J, Osca-Verdegal R, Pallardó FV, et al.. Oxidative stress and inflammation in COVID-19-associated sepsis: the potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants (Basel). 2020, 9:936. 10.3390/antiox9100936 · DOI
  172. Aygun H. Vitamin D can prevent COVID-19 infection-induced multiple organ damage. Naunyn Schmiedebergs Arch Pharmacol. 2020, 393:1157-60. 10.1007/s00210-020-01911-4 · DOI
  173. Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw Open. 2020, 3:e2019722. 10.1001/jamanetworkopen.2020.19722 · DOI · Paper page
  174. Ebadi M, Montano-Loza AJ. Perspective: improving vitamin D status in the management of COVID-19. Eur J Clin Nutr. 2020, 74:856-9. 10.1038/s41430-020-0661-0 · DOI
  175. Yancy CW. COVID-19 and African Americans. JAMA. 2020, 323:1891-2. 10.1001/jama.2020.6548 · DOI · Paper page
  176. Mohan M, Cherian JJ, Sharma A. Exploring links between vitamin D deficiency and COVID-19. PLoS Pathog. 2020, 16:e1008874. 10.1371/journal.ppat.1008874 · DOI
  177. Biricik E, Güneş Y. Vitamin D and anaesthesia. Turk J Anaesthesiol Reanim. 2015, 43:269-73. 10.5152/TJAR.2015.28482 · DOI
  178. Quraishi SA, Bittner EA, Blum L, McCarthy CM, Bhan I, Camargo CA Jr. Prospective study of vitamin D status at initiation of care in critically ill surgical patients and risk of 90-day mortality. Crit Care Med. 2014, 42:1365-71. 10.1097/CCM.0000000000000210 · DOI
  179. Li Y, Ding S. Serum 25-Hydroxyvitamin D and the risk of mortality in adult patients with Sepsis: a meta-analysis. BMC Infect Dis. 2020, 20:189. 10.1186/s12879-020-4879-1 · DOI
  180. Rech MA, Hunsaker T, Rodriguez J. Deficiency in 25-hydroxyvitamin D and 30-day mortality in patients with severe sepsis and septic shock. Am J Crit Care. 2014, 23:e72-9. 10.4037/ajcc2014723 · DOI
  181. Turan A, Hesler BD, You J, et al.. The association of serum vitamin D concentration with serious complications after noncardiac surgery. Anesth Analg. 2014, 119:603-12. 10.1213/ANE.0000000000000096 · DOI
  182. Joshi A, Bhadade R, Varthakavi PK, DeSouza R, Bhagwat NM, Chadha MD. Vitamin D deficiency is associated with increased mortality in critically ill patients especially in those requiring ventilatory support. Indian J Endocrinol Metab. 2014, 18:511-5. 10.4103/2230-8210.137504 · DOI
  183. Smith JM, Cancienne JM, Brockmeier SF, Werner BC. Vitamin D deficiency and total shoulder arthroplasty complications. Shoulder Elbow. 2021, 13:99-105. 10.1177/1758573220906520 · DOI
  184. Amrein K, Papinutti A, Mathew E, Vila G, Parekh D. Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa. Endocr Connect. 2018, 7:R304-15. 10.1530/EC-18-0184 · DOI
  185. Haugen M, Brantsaeter AL, Trogstad L, Alexander J, Roth C, Magnus P, Meltzer HM. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology. 2009, 20:720-6. 10.1097/EDE.0b013e3181a70f08 · DOI · Paper page
  186. Nair P, Venkatesh B, Center JR. Vitamin D deficiency and supplementation in critical illness—the known knowns and known unknowns. Crit Care. 2018, 22:276. 10.1186/s13054-018-2185-8 · DOI
  187. Holick MF. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med. 2008, 29:361-8. 10.1016/j.mam.2008.08.008 · DOI · Paper page
  188. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol. 2008, 68:315-22. 10.1111/j.1365-2265.2005.02226.x · DOI · Paper page

Cited by

Metadata

Authors
Haider, F., Ghafoor, H., Hassan, O. F., Farooqui, K., Bel Khair, A. O. M., & Shoaib, F.
Venue
Cureus
Publisher
Springer Science and Business Media LLC
Published
2023-11-30
ISSN
2168-8184
DOI
10.7759/cureus.49734
Cited by
24
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.